The benefits of combined treatment with corticosteroids and long-acting beta agonists
暂无分享,去创建一个
[1] I. Pavord,et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. , 2006, American journal of respiratory and critical care medicine.
[2] D. Postma,et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease , 2005, Thorax.
[3] N. Pride,et al. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. , 2005, American journal of respiratory and critical care medicine.
[4] I. Pavord,et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease , 2005, Thorax.
[5] P. Calverley,et al. Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.
[6] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[7] R. Sansores,et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[8] I. Pavord,et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial , 2000, The Lancet.
[9] S. Spencer,et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.
[10] Williams Mh,et al. OBSTRUCTIVE PULMONARY DISEASE , 1964 .
[11] Malcolm W Johnson. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.